Potential Price Increase for Prestige Consumer Healthcare Inc. (PBH) After Recent Insider Activity


In a filing, Prestige Consumer Healthcare Inc. revealed its Chief Executive Officer Lombardi Ronald M. unloaded Company’s shares for reported $2.15 million on Aug 08. In the deal valued at $65.57 per share,32,800 shares were sold. As a result of this transaction, Lombardi Ronald M. now holds 270,557 shares worth roughly $ 15.79 million.

Top 5 EV Tech Stocks to Buy for 2023

The electric vehicle boom is accelerating – and fast. According a new report published by BloombergNEF, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now. Get our free report, "Top 5 EV Tech Stocks to Buy for 2023".

Click Here to Download the FREE Report.


Then, Sacco Christine sold 55,294 shares, generating $3,321,511 in total proceeds. Upon selling the shares at $60.07, the Chief Financial Officer now owns 26,969 shares.

Before that, Mekhail Adel sold 17,194 shares. Prestige Consumer Healthcare Inc. shares valued at $1,072,286 were divested by the EVP, Marketing & Sales at a price of $62.36 per share. As a result of the transaction, Mekhail Adel now holds 18,681 shares, worth roughly $1.09 million.

Canaccord Genuity initiated its Prestige Consumer Healthcare Inc. [PBH] rating to a Buy in a research note published on Friday, November 17, 2022; the price target was $71. PT values the company’s stock at a premium of 17.79 to its Friday closing price.

Price Performance Review of PBH

On Friday, Prestige Consumer Healthcare Inc. [NYSE:PBH] saw its stock jump 0.07% to $58.37. On the same session, the stock had its day’s lowest price of $58.29, but rose to a high of $59.00. Over the last five days, the stock has lost -3.09%. Prestige Consumer Healthcare Inc. shares have fallen nearly -6.76% since the year began. Nevertheless, the stocks have risen 15.40% over the past one year. While a 52-week high of $68.54 was reached on 08/07/23, a 52-week low of $48.51 was recorded on 06/05/23. SMA at 50 days reached $61.10, while 200 days put it at $61.23. A total of 0.19 million shares were traded, compared to the trading of 0.2 million shares in the previous session.

Levels Of Support And Resistance For PBH Stock

The 24-hour chart illustrates a support level at 58.11, which if violated will result in even more drops to 57.84. On the upside, there is a resistance level at 58.82. A further resistance level may holdings at 59.26. The Relative Strength Index (RSI) on the 14-day chart is 34.05, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -1.09, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 96.58%. Stochastics %K at 5.86% indicates the stock is a buying.

How much short interest is there in Prestige Consumer Healthcare Inc.?

A steep rise in short interest was recorded in Prestige Consumer Healthcare Inc. stocks on Aug 14, 2023, growing by 70000.0 shares to a total of 1.4 million shares. Yahoo Finance data shows the prior-month short interest on Jul 13, 2023 was 1.33 million shares. There was a rise of 5.0%, which implies that there is a positive sentiment for the stock. In spite of short shares comprising just 3.96% of the overall stock float, the days-to-cover ratio (short ratio) rose to 6.01.

According to FactSet, Prestige Consumer Healthcare Inc.’s share price will average $72.80 in the next year, based on opinions of analysts polled by the firm. This is up nearly 23.44 percent from its previous closing price of $58.33. Analysts expect Prestige Consumer Healthcare Inc. stock to reach the higher price of $82.00, while the lowest price estimate is $60.00. However, 6 analysts have rated PBH stock as a Buy in their predictions for 2023.


Please enter your comment!
Please enter your name here